Advertisement
Screener

CELLULAR BIOMEDICINE GROUP, INC. Quick Ratio

CELLULAR BIOMEDICINE GROUP, INC. Quick Ratio

  • Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2020-09-30..

Quick ratio

Overview →

Financial period ending 2020-09-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
Quick ratio · latest quarter(m)Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2020-09-30.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Cash, securities and trade receivables(m)Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current
Current obligations59.30M USDLiabilities, Current
Cash and equivalents26.03M USDCash and Cash Equivalents, at Carrying Value
Short-term securities(m)
Customer receivables32.30K USDAccounts Receivable, after Allowance for Credit Loss, Current
Inventory · excluded from quick assets(m)Inventory, Net

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingCash, securities and trade receivables (USD)Current obligations (USD)Cash and equivalents (USD)Short-term securities (USD)Customer receivables (USD)Inventory · excluded from quick assets (USD)Quick ratio
2020-09-30(m)$59.30M$26.03M(m)$32.30K(m)(m)
2020-06-30(m)$28.45M$13.58M(m)(m)(m)(m)
2020-03-31(m)$23.53M(m)(m)(m)(m)(m)
2019-12-31(m)$23.67M$0.00(m)$0.00(m)(m)
2019-09-30(m)$25.86M(m)(m)$0.00(m)(m)
2019-06-30(m)$22.17M(m)(m)$0.00(m)(m)
2019-03-31(m)$14.69M(m)(m)$0.00(m)(m)
2018-12-31(m)$8.04M$52.81M(m)$787.00(m)(m)
2018-09-30(m)$5.93M(m)(m)$37.59K(m)(m)
2018-06-30(m)$4.80M(m)(m)$133.88K(m)(m)
2018-03-31(m)$5.21M(m)(m)$128.88K(m)(m)
2017-12-31(m)$3.68M(m)(m)$202.89K(m)(m)
2017-09-30(m)$3.86M(m)(m)$145.38K(m)(m)
2017-06-30(m)$4.52M(m)(m)$91.46K(m)(m)
2017-03-31(m)$2.01M(m)(m)$79.60K(m)(m)
2016-12-31(m)$2.36M(m)(m)$39.97K$0.00(m)
2016-09-30(m)$1.93M(m)(m)$53.48K$253.17K(m)
2016-06-30(m)$2.20M(m)(m)$330.86K$313.84K(m)
2016-03-31(m)$3.17M(m)(m)$582.71K$486.35K(m)
2015-12-31(m)$3.02M(m)(m)$630.33K$390.89K(m)
2015-09-30(m)$4.72M(m)(m)$410.76K$422.08K(m)
2015-06-30(m)$5.22M(m)(m)$445.20K$400.09K(m)
2015-03-31(m)$5.03M(m)(m)$339.97K$277.87K(m)
2014-12-31(m)$4.08M(m)(m)$141.03K$372.25K(m)
2014-09-30(m)$4.90M(m)(m)$175.09K$347.80K(m)
2014-06-30(m)$2.52M(m)(m)$24.00K$156.49K(m)
2014-03-31(m)$1.82M(m)(m)$34.58K$133.69K(m)
2013-12-31(m)$2.20M(m)(m)$10.58K$119.12K(m)
2013-09-30(m)$1.89M(m)(m)(m)$39.98K(m)
2013-06-30(m)$2.28M(m)(m)(m)$30.44K(m)
2013-03-31(m)$2.94M(m)(m)(m)$38.84K(m)
2012-12-31(m)$595.23K(m)(m)$20.68K$37.24K(m)
2012-09-30(m)$4.55M(m)(m)(m)(m)(m)
2012-06-30(m)$1.80M(m)(m)(m)(m)(m)
2012-03-31(m)$1.89M(m)(m)(m)(m)(m)
2011-12-31(m)$1.97M(m)(m)(m)(m)(m)
2011-09-30(m)$1.75M(m)(m)(m)(m)(m)
2011-06-30(m)$1.96M(m)(m)(m)(m)(m)
2010-12-31(m)$1.61M(m)(m)(m)(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.